Showing results (71-80 of 97) with videos related to
Sort By:
Pageof 10
Journal of Virology|February 6, 2015
CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus (SIV) vaccine enhances protection against neutralization-resistant mucosal SIV infectionSuefen Kwa, Shanmugalakshmi Sadagopal, Xiaoying Shen, et al.Virology|August 19, 2007
GM-CSF DNA: an adjuvant for higher avidity IgG, rectal IgA, and increased protection against the acute phase of a SHIV-89.6P challenge by a DNA/MVA immunodeficiency virus vaccineLilin Lai, Dalma Vödrös, Pamela A Kozlowski, et al.Plos Pathogens|October 17, 2013
O-mannosylation of the Mycobacterium tuberculosis adhesin Apa is crucial for T cell antigenicity during infection but is expendable for protectionSubhadra Nandakumar, Sunil Kannanganat, Karen M Dobos, et al.Open Forum Infectious Diseases|March 24, 2016
Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus VaccineVenkateswarlu Chamcha, Sunil Kannanganat, Sailaja Gangadhara, et al.Cell Reports|March 2, 2022
Structure-guided changes at the V2 apex of HIV-1 clade C trimer enhance elicitation of autologous neutralizing and broad V1V2-scaffold antibodiesAnusmita Sahoo, Edgar A Hodge, Celia C LaBranche, et al.AIDS Research and Human Retroviruses|July 10, 2004
Multiprotein HIV type 1 clade B DNA/MVA vaccine: construction, safety, and immunogenicity in MacaquesJames M Smith, Rama Rao Amara, Harold M McClure, et al.AIDS Research and Human Retroviruses|January 15, 2005
DNA/MVA vaccine for HIV type 1: effects of codon-optimization and the expression of aggregates or virus-like particles on the immunogenicity of the DNA primeJames M Smith, Rama Rao Amara, David Campbell, et al.Journal of Virology|November 21, 2008
Neutralization-sensitive R5-tropic simian-human immunodeficiency virus SHIV-2873Nip, which carries env isolated from an infant with a recent HIV clade C infectionNagadenahalli B Siddappa, Ruijiang Song, Victor G Kramer, et al.Vaccine|December 20, 2011
SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responsesLilin Lai, Sue-Fen Kwa, Pamela A Kozlowski, et al.Frontiers in Immunology|February 6, 2026
Immunogenicity and protection mediated by dmLT and alum adjuvants for an HIV-1 vaccineKasey Stokdyk, Anusmita Sahoo, Sailaja Gangadhara, et al.Pageof 10